⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 4, 2024Open Access

Supplemental Table S4 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer

Adrianne Wallace-Povirk Carrie O’Connor Aamod S. Dekhne Xun Bao Md. Junayed Nayeen Mathew Schneider Jade M. Katinas Jennifer Wong-Roushar Seongho Kim Lisa Polin Jing Li Jessica B. Back Charles E. Dann Aleem Gangjee Zhanjun Hou Larry H. Matherly

View Full Paper

Ask AI

Bookmark

Share

Abstract

This table shows IC50 values for antiproliferative activities toward EOC versus normal ovary cell lines by 5-substituted pyrrolo[3,2-d]pyrimidine inhibitors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wallace-Povirk et al. (2024) studied this question.

synapsesocial.com/papers/68e664bab6db6435875f16d3 https://doi.org/10.1158/1535-7163.25964869

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table S4 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
2Supplemental Table S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
3Supplemental Table S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
4Supplemental Table S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
5Supplemental Table S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024